Clinical Trials Logo

Lung Diseases, Obstructive clinical trials

View clinical trials related to Lung Diseases, Obstructive.

Filter by:

NCT ID: NCT02343055 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

COPE With COPD Trial

Start date: October 2011
Phase: N/A
Study type: Interventional

The overall objective of this study is to evaluate a collaborative self-management intervention in patients with moderate to severe COPD in a primary care population. To achieve this objective the investigators developed a diagnostic and treatment pathway for the management of COPD in primary care that is based on national guidelines and focused on patient self-management.

NCT ID: NCT02331940 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients

Start date: March 2010
Phase: N/A
Study type: Interventional

The aim of this study was to compare the tiotropium Respimat Soft Mist Inhaler and the HandiHaler in terms of their effects on sleeping oxygen saturation (SaO2) and sleep quality in patients with COPD.

NCT ID: NCT02329873 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Respiratory Rehabilitation Exercises in Older Adults With Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Start date: November 2011
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial was to evaluate the effects of a respiratory rehabilitation exercise training package on dyspnea, cough, exercise tolerance, and sputum expectoration of hospitalized elderly patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Using purposive sampling, 61 participants were recruited and randomly assigned to either the experimental group (n = 30) or the control group (n = 31). The experimental group participants received the respiratory rehabilitation exercise training twice a day and 10-30 minutes per session for four days. The control group participants received usual care and health education. Data were collected at baseline and at the end of the four-day intervention.

NCT ID: NCT02321215 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation

Effectiveness and Feasibility of Delivering an Education Program to Patients With an Acute Exacerbation of COPD

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if it is effective and feasible to provide a chronic obstructive pulmonary disease (COPD) education program to patients admitted with an acute exacerbation of COPD.

NCT ID: NCT02314338 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

The Short Physical Performance Battery in Chronic Obstructive Pulmonary Disease (COPD)

Start date: September 2014
Phase: N/A
Study type: Interventional

Patients with COPD often have limitations to physical performance. There are several tests for evaluating physical performance, unfortunately many of them can be time consuming and require specialized equipment an substantial space. Short physical performance battery is a simple test that requires little resources and can be performed both at institutions and in the homes of patients. SPPB has high predictive abilities in identifying older adults at greater risk for mortality, nursing home admission, hospitalization, and incidence of disability. The investigators would like to evaluate possible changes in the SPPB score after a 4-week rehabilitation program. The investigators would also like to look at possible relationships between the SPPB and other physical performance measures, dyspnea, anxiety, depression, fatigue, and health related quality of life.

NCT ID: NCT02307799 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology

RESPECT
Start date: June 2012
Phase:
Study type: Observational

The aim of the RESPECT study is to gain a better understanding of the prevalence, pathogenesis and symptoms of early chronic obstructive pulmonary disease (COPD). This study seeks to address the following specific objectives/research questions: 1) to estimate the prevalence of airflow limitation (AL) and COPD in adults 35-70 years of age in St.Petersburg and Arkhangelsk based on sex, age, environmental conditions, socioeconomic status and smoking status; 2) to compare the prevalence of COPD in the study population based on the Global Strategy for Diagnosis, Management and Prevention of COPD (GOLD) and lower limit of normal (LLN) criteria; 3) to identify the diagnostic value of various signs, symptoms and background characteristics for the diagnosis of COPD; 4) to determine whether differences in background characteristics and inflammatory biomarkers are evident between smokers with and without COPD; and 5) to describe co-morbidity, functionality and global health status in a cohort of newly diagnosed COPD patients.

NCT ID: NCT02306473 Completed - Asthma Clinical Trials

The Leaky Lung Test

Start date: October 2015
Phase: Early Phase 1
Study type: Interventional

This is a clinical trial designed to test the hypothesis that measuring the absorption and excretion of inhaled mannitol will provide a clinically useful marker of airway epithelial permeability in asthma.

NCT ID: NCT02305940 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients

Start date: July 2014
Phase: Phase 3
Study type: Interventional

This study investigates if long term use of the antibiotic doxycycline can reduce exacerbations in COPD patients. Half of the patients will receive doxycycline which the other half will receive a placebo.

NCT ID: NCT02300220 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Targeted Retreatment of COPD Exacerbations

Start date: May 5, 2014
Phase: Phase 3
Study type: Interventional

This study investigates the effects of targeted re-treatment of patients who do not recover from an exacerbation of COPD. Half of the patients will receive ciprofloxacin while the other half will receive a placebo.

NCT ID: NCT02300090 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD)

Me&MyCOPD
Start date: October 26, 2016
Phase:
Study type: Observational [Patient Registry]

A real world study to determine the effectiveness of a patient support service to aid COPD patients in their self management.